|
|
||||||||
From the Raymond Escourolle Neuropathology Laboratory (Drs. Hauw and Sazdovitch, and N. Privat) and INSERM U 360 (Drs. Hauw, Sazdovitch, Delasnerie-Lauprêtre, Brandel, and Alpérovitch, and N. Privat), Pitié-Salpêtrière Hospital, Association Claude Bernard, Pierre et Marie Curie University, Paris; Central Laboratory of Biochemistry (Drs. Laplanche and Peoch), Lariboisière Hospital, Association Claude Bernard, Paris; Hôpital Neurologique (Dr. Kopp), Lyon 2 University, Lyon; Pathology Department (Dr. Kemeny), Clermont-Ferrand University Hospital, Clermont-Ferrand; and CEA, CRSSA (Drs. Deslys and Dormont), Fontenay aux Roses, France.
Address correspondence and reprint requests to Pr. J.-J. Hauw, Laboratoire de Neuropathologie Raymond Escourolle, Hôpital de la Salpêtrière, 47, Bd. de lHôpital, 75013 Paris, France; e-mail: jean-jacques.hauw{at}psl.ap-hop-paris.fr
OBJECTIVES: To determine the contribution of methionine/valine (Met/Val) polymorphism at codon 129 of the prion protein (PrP) gene in the neuropathologic pattern and mechanisms of lesion development in sporadic CreutzfeldtJakob disease.
BACKGROUND: CreutzfeldtJakob disease is a transmissible spongiform encephalopathy characterized by a conformational change of PrP and a variety of PrP deposits in the brain, some of which aggregate into amyloid plaques.
METHODS: The authors semiquantitatively assessed neuropathologic lesions and performed PrP immunolabeling in 70 patients (39 Met/Met, 11 Met/Val, 20 Val/Val) who had died in France between 1994 and 1998.
RESULTS: Met/Met cases (mild lesions mostly involving the occipital areas, low PrP load, few focal PrP nonamyloid deposits, no amyloid plaques) contrasted with Met/Val cases (marked lesions especially in the parahippocampal gyrus, high PrP load, numerous amyloid plaques) and with Val/Val cases (younger patients, longer course of disease: 11.5 ± 3 months, and distinct neuropathology: severe lesions heavily involving the hippocampal formation and basal ganglia, high PrP load, numerous focal nonamyloid deposits, rare amyloid plaques). The course of Val/Val patients younger than age 55 was particularly long (19.9 ± 7 months), and the isocortex bore the brunt of the pathology, suggesting a distinct variety.
CONCLUSIONS: Polymorphism at codon 129 modulates the phenotype of sporadic CreutzfeldtJakob disease. The Val genotype enhances the production of proteinase-resistant PrP, and the Met/Val genotype facilitates its aggregation into amyloid plaques.
Key words: CreutzfeldtJakob diseasePrion protein genotypeNeuropathology.
This article has been cited by other articles:
![]() |
S. Haik, D. Galanaud, M. G. Linguraru, K. Peoc'h, N. Privat, B. A. Faucheux, N. Ayache, J.-J. Hauw, D. Dormont, and J.-P. Brandel In Vivo Detection of Thalamic Gliosis: A Pathoradiologic Demonstration in Familial Fatal Insomnia Arch Neurol, April 1, 2008; 65(4): 545 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Basset-Leobon, E. Uro-Coste, K. Peoc'h, S. Haik, V. Sazdovitch, M. Rigal, O. Andreoletti, J.-J. Hauw, and M.-B. Delisle Familial Creutzfeldt-Jakob Disease With an R208H-129V Haplotype and Kuru Plaques. Arch Neurol, March 1, 2006; 63(3): 449 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. -M. Rodriguez, K. Peoc'h, S. Haik, C. Bouchet, L. Vernengo, G. Manana, R. Salamano, L. Carrasco, M. Lenne, P. Beaudry, et al. A novel mutation (G114V) in the prion protein gene in a family with inherited prion disease Neurology, April 26, 2005; 64(8): 1455 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Haik, J. P. Brandel, D. Salomon, V. Sazdovitch, N. Delasnerie-Laupretre, J. L. Laplanche, B. A. Faucheux, C. Soubrie, E. Boher, C. Belorgey, et al. Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects Neurology, December 28, 2004; 63(12): 2413 - 2415. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Meissner, K. Kohler, K. Kortner, M. Bartl, U. Jastrow, B. Mollenhauer, A. Schroter, M. Finkenstaedt, O. Windl, S. Poser, et al. Sporadic Creutzfeldt-Jakob disease: Magnetic resonance imaging and clinical findings Neurology, August 10, 2004; 63(3): 450 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tahiri-Alaoui, A. C. Gill, P. Disterer, and W. James Methionine 129 Variant of Human Prion Protein Oligomerizes More Rapidly than the Valine 129 Variant: IMPLICATIONS FOR DISEASE SUSCEPTIBILITY TO CREUTZFELDT-JAKOB DISEASE J. Biol. Chem., July 23, 2004; 279(30): 31390 - 31397. [Abstract] [Full Text] [PDF] |
||||
![]() |
Neuropathologic Variations and Codon 129 Polymorphism in Sporadic CJD Journal Watch Neurology, August 9, 2000; 2000(809): 7 - 7. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |